Tasmanian devils: when cancer spreads as living cells

The Tasmanian devil (Sarcophilus harrisii) faces an unusual conservation threat: cancer cells can move between animals and grow as a new tumour in the recipient. Devil facial tumour disease (DFTD) is not caused by a virus that makes each host develop its own cancer. The tumour itself is transmissible tissue. That distinction explains why the disease has fascinated cancer researchers and why its spread has been so difficult to manage in free-ranging devils.

The first recognised outbreak was reported in 1996. Researchers later identified a second, independently evolved lineage, now called DFT2. The two lineages are not merely stages of one tumour. They arose separately and both demonstrate that transmissible cancer can emerge more than once in this species.

How a cancer becomes transmissible

Tasmanian devils often bite one another during mating, feeding and social disputes. If a bite transfers viable tumour cells into damaged tissue, those cells can establish a new growth. The disease therefore spreads through contact between animals, while the infectious material is a clone of cancer cells rather than a microorganism.

DFT1 was recognised in north-eastern Tasmania in the 1990s and subsequently spread through much of the island. DFT2 was detected later in south-eastern Tasmania. Research traces the two cancers to separate founder cells, both associated with the Schwann-cell lineage. The detail matters: a second emergence means that eliminating one cancer lineage would not automatically remove the biological possibility of another.

Devils’ immune response to transplanted tumour cells is unusual, but it is not accurate to describe them as having no immune system or no genetic variation. DFTD populations and hosts continue to evolve. Studies have reported changes in tumour biology and evidence of host variation in disease outcomes. These findings are promising research questions, not proof that natural resistance has already solved the crisis.

What the disease does to an animal

Visible tumours can develop around the face and mouth, interfering with feeding and causing further injury or infection. The severity and course vary, and a photograph of a sick animal cannot establish how common the disease is across Tasmania. Field teams use capture, examination and repeated monitoring to record disease prevalence and survival at particular sites.

Older summaries sometimes repeat a single percentage decline as though it applied to every devil population. In reality, the impact has varied between regions and over time. Tasmania’s Save the Tasmanian Devil Program tracks abundance, breeding output, disease prevalence and road mortality through field surveys. The programme was established in 2003, after the rapid decline became a major conservation concern.

Conservation has to work in the wild

Insurance populations in managed care can preserve animals and genetic material outside disease-affected areas. They are useful safeguards, but a captive population is not a substitute for devils living across a functioning Tasmanian landscape. Disease-free populations and carefully planned translocations must be managed alongside monitoring in the wild, veterinary research and habitat protection.

Research into vaccines and immune responses may improve future options. A vaccine is not a simple cure for an established tumour, and field trials must show that an intervention works safely under real ecological conditions. Meanwhile, camera surveys, tagging, tissue samples and health checks help researchers distinguish a true population change from a change in how often animals are detected.

Why the devil matters beyond Tasmania

As a large native scavenger, the devil consumes carcasses and interacts with other parts of the island’s food web. The exact ecosystem effects of its decline depend on place and should not be reduced to a claim that one predator controls every invasive species or disease. Its ecological role is one reason conservation focuses on viable wild populations, not just on keeping individuals alive in breeding facilities.

The case also broadens how people think about disease. Most cancers are not contagious between individuals. DFTD is a rare exception in which the cells themselves cross between hosts. Other conservation stories, such as the gharial recovery effort in Indian rivers, involve different pressures and different tools; comparing them helps show why conservation plans must match the biology of each species.

A threat that does not dictate the ending

DFTD has caused severe losses and remains a serious threat. It does not make extinction inevitable on a fixed timetable. Devils persist in the wild, disease outcomes vary, and research continues to test how host and tumour populations change. The responsible conclusion is neither reassurance nor doom: long-term survival depends on sustained field evidence, flexible management and protection against additional pressures such as road deaths and habitat disturbance.